Hosking Partners LLP lifted its holdings in Coupang, Inc. (NYSE:CPNG - Free Report) by 58.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 926,236 shares of the company's stock after purchasing an additional 340,855 shares during the quarter. Hosking Partners LLP owned 0.05% of Coupang worth $20,359,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Proficio Capital Partners LLC bought a new position in Coupang during the 4th quarter valued at about $854,000. New York Life Investment Management LLC purchased a new position in Coupang during the fourth quarter valued at approximately $349,000. BankPlus Trust Department bought a new position in shares of Coupang in the 4th quarter worth $225,000. IFP Advisors Inc raised its holdings in Coupang by 3.8% in the fourth quarter. IFP Advisors Inc now owns 12,734 shares of the company's stock worth $280,000 after purchasing an additional 469 shares in the last quarter. Finally, Olympiad Research LP bought a new position in shares of Coupang during the 4th quarter worth approximately $314,000. 83.72% of the stock is currently owned by institutional investors.
Coupang Stock Performance
Shares of NYSE CPNG traded down $0.43 during midday trading on Tuesday, reaching $23.39. 9,309,655 shares of the stock were exchanged, compared to its average volume of 8,926,504. The company has a quick ratio of 0.86, a current ratio of 1.13 and a debt-to-equity ratio of 0.28. The firm has a market cap of $42.07 billion, a price-to-earnings ratio of 41.03, a PEG ratio of 52.20 and a beta of 1.11. The firm has a 50-day simple moving average of $23.24 and a two-hundred day simple moving average of $23.90. Coupang, Inc. has a twelve month low of $17.34 and a twelve month high of $26.91.
Analyst Ratings Changes
Several research analysts recently issued reports on CPNG shares. Barclays set a $35.00 target price on Coupang and gave the company an "overweight" rating in a research report on Thursday, February 27th. Deutsche Bank Aktiengesellschaft upgraded shares of Coupang from a "hold" rating to a "buy" rating and set a $28.50 price objective on the stock in a report on Wednesday, February 26th. Citigroup lowered their target price on shares of Coupang from $31.00 to $28.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. Finally, Mizuho upped their price target on shares of Coupang from $25.00 to $27.00 and gave the company a "neutral" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $29.17.
View Our Latest Research Report on CPNG
Insider Activity
In related news, VP Pranam Kolari sold 8,459 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $22.98, for a total value of $194,387.82. Following the transaction, the vice president now directly owns 136,806 shares of the company's stock, valued at approximately $3,143,801.88. This trade represents a 5.82 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 13.60% of the company's stock.
About Coupang
(
Free Report)
Coupang, Inc, together with its subsidiaries owns and operates retail business through its mobile applications and Internet websites primarily in South Korea. The company operates through Product Commerce and Developing Offerings segments. It sells various products and services in the categories of home goods and décor products, apparel, beauty products, fresh food and groceries, sporting goods, electronics, and everyday consumables, as well as travel, and restaurant order and delivery services.
Read More

Before you consider Coupang, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Coupang wasn't on the list.
While Coupang currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.